General

Methylprednisolone for the Treatment of Patients with Acute Spinal Cord Injuries: A Propensity Score-Matched Cohort Study from a Canadian Multi-Center Spinal Cord Injury Registry

Evaniew N, Noonan VK, Fallah N, Kwon B, Rivers CS, Ahn H, Bailey CS, Christie SD, Fourney DR, Hurlbert RJ, Linassi AG, Fehlings MG, Dvorak MF, and The RHSCIR Network. Journal of Neurotrauma. November 1, 2015 doi: 10.1089/neu.2015.3963. 

Summary: In a matched case-control analysis using national RHSCIR data, no evidence was found that methylprednisolone improves neurologic outcome following traumatic spinal cord injury as found in the controversial and much criticized 1990 NASCIS-II trial. This supports the downgrade of methylprednisolone as a treatment recommendation to a treatment option, and the evidence that it may increase odds of complications.

The Application of Operations Research Methodologies to the Delivery of Care Model for Traumatic Spinal Cord Injury: The Access to Care and Timing Project

Noonan VK, Soril L, Atkins D, Lewis R, Santos A, Fehlings MG, Burns AS, Singh A, Dvorak MF. J Neurotrauma. 29:2272–2282, September 1, 2012.

Spinal Cord Injury Clinical Registries: Improving Care across the SCI Care Continuum by Identifying Knowledge Gaps

Dvorak MF, Cheng CL, Fallah N, Santos A, Atkins D, Humphreys S, Rivers CS, White BAB, Ho C, Ahn H, Kwon BK, Christie S, Noonan VK. J Neurotrauma. 2017 Jul 26. doi: 10.1089/neu.2016.4937. [Epub ahead of print]

Methodology of the Access to Care and Timing Simulation Model for Traumatic Spinal Cord Injury Care

Santos A, Fallah N, Lewis R, Dvorak MF, Fehlings MG, Burns AS, Noonan VK, Cheng CL, Chan E, Singh A, Belanger LM, Atkins D. J Neurotrauma. 2017 Mar 12. doi: 10.1089/neu.2016.4927. [Epub ahead of print] 

View summary on the ACT Focus Issue page